Aptahem recalls outstanding convertible notes to Yorkville

Aptahem AB (publ) today announces that the company intends to recall the outstanding amount of convertible notes held by YA II PN Ltd, a fund represented by the U.S.-based Yorkville Advisors Global (”Yorkville”). Through a mutual agreement, Aptahem will...

Read More

Endpoints News article: Aptahem – a Swedish biotech aiming to win the race against sepsis

In the fight to save a person affected by sepsis every second counts – each hour that passes increases the risk of death with 8 percent. It is literally a race against time, a race that the healthcare services...

Read More